Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study.

Chen, Min; Chen, Qian; Xiao, Xin-Yu; Feng, Si-Jia; Wang, Xiao-Ying; Tang, Tai-Chun; Zheng, Hui

Chen, Min; Chen, Qian; Xiao, Xin-Yu; Feng, Si-Jia; Wang, Xiao-Ying; Tang, Tai-Chun; Zheng, Hui.

Afiliación

Chen M; Department of Colorectal Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Chen Q; The Third Hospital/Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xiao XY; The Third Hospital/Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Feng SJ; The Third Hospital/Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Wang XY; The Third Hospital/Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Tang TC; Department of Colorectal Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Zheng H; The Third Hospital/Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Front Pharmacol ; 13: 1079953, 2022.

Article en En | MEDLINE | ID: mdl-36618924

Palabras clave

TNF inhibition; cancer prevention; colorectal cancer; drug target; mendelian randomization

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google